Loading...
Loading...
AstraZeneca
AZN today announced that BRILINTA (ticagrelor) tablets received Plan Preferred Tier 2 formulary access on Medco Health Solutions' National commercial formulary and Preferred Brand formulary status on its Medicare Part D drug list.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in